does tirzepatide cause kidney issues New Cleveland Clinic research finds is associated with a 16% lower risk of major heart and complications compared with dulaglutide in people with Type 2 diabetes and heart disease., FDA SIDE EFFECTS UPDATE: Kidney

This symptom should never be attributed to typical gastrointestinal adjustment without clinical assessment

These multifaceted effects suggest that Tirzepatide could be repurposed as a disease-modifying treatment for early-stage neurodegeneration, especially in diabetic or prediabetic patients

These hormones help you control appetite spikes, improve your insulin sensitivity, and make you feel fuller

FDAs Concerns with Unapproved GLP-1 Drugs Used for Weight Loss

Last Published 05.01.2026 Effective Date: 05.01.2026 This policy addresses the use of Amondys 45 (casimersen) for the treatment of Duchenne muscular dystrophy (DMD)

Manufactured by Eli Lilly, Zepbound was approved by the FDA in November 2023 and has rapidly become the most prescribed injectable obesity-management medication in the United States